Skip to content

Development of a Weight Maintenance Intervention for Bariatric Surgery Patients

Development of a Weight Maintenance Intervention for Bariatric Surgery Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03246672
Acronym
MAINTAIN-B
Enrollment
33
Registered
2017-08-11
Start date
2018-01-03
Completion date
2018-07-31
Last updated
2019-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Morbid

Keywords

obesity, morbid

Brief summary

Although bariatric surgery is highly effective for inducing significant weight loss and resolution of comorbidities, weight regain following surgery is a common problem. This pilot study will test the feasibility and acceptability of an intervention designed to help bariatric surgery patients maintain weight loss. Findings from this pilot will provide the foundation for a randomized controlled trial to evaluate the efficacy of the intervention.

Detailed description

The first intervention telephone call will occur one week following the baseline assessment. Calls will be made weekly in the first month (weeks 1, 2, 3, 4) and biweekly calls during months 2-4 (weeks 6, 8, 10, 12, 14). The goal of this intervention is to increase adherence to recommendations that patients are already receiving from their bariatric team as part of standard of care. Thus, each call will address maintenance skill building and anticipatory problem solving based on the processes outlined in the investigators' conceptual model and operationalized in the investigators' previous weight loss maintenance protocol. Relapse prevention planning will help patients identify situations in which overeating is common in the bariatric population (e.g., loss of control eating related to emotions, disinhibition).

Interventions

Participants will receive calls at weeks 1, 2, 3, 4, 6, 8, 10, 12, and 14 that focus on satisfaction with outcomes of behavior change, self-monitoring, relapse planning, and social support.

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

All participants receive the intervention

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Bariatric surgery at a participating VA site * Laparoscopic Roux-en-Y gastric bypass (RYGB) or laparoscopic vertical sleeve gastrectomy (SG) six to 18 months prior to the time of data pull * English as preferred language * Regular access to a telephone

Exclusion criteria

* Receipt of procedure to prevent gastric cancer * Revisional bariatric surgery * Hearing impairment * Cancer not in remission

Design outcomes

Primary

MeasureTime frameDescription
Recruitment Rateweek 0Percentage of contacted patients who consent to be in the study
Retention Rate16-week outcome assessmentPercentage of patients with baseline data who complete 16-week outcome assessments

Secondary

MeasureTime frameDescription
Weight16 weeksPatient weight obtained from the electronic medical record on the clinical visit date closest to the 16-week study assessment date

Countries

United States

Participant flow

Recruitment details

Participants were recruited from January to March 2018. These participants were identified using electronic medical record data indicating that they had bariatric surgery for weight loss at one of four VA hospitals: West Roxbury, MA; Long Beach, CA; Palo Alto, CA; and Ann Arbor, MI.

Pre-assignment details

33 participants provided verbal consent. Of those, 3 were unable to be reached and 30 were reached by telephone to complete baseline measures and were scheduled for their first intervention phone call. Of those 30, 29 participants were reached for the first intervention phone call, and 1 participant unable to be reached for further participation.

Participants by arm

ArmCount
Maintenance
behavioral intervention to increase adherence to lifestyle recommendations maintenance intervention: Participants will receive calls at weeks 1, 2, 3, 4, 6, 8, 10, 12, and 14 that focus on satisfaction with outcomes of behavior change, self-monitoring, relapse planning, and social support.
30
Total30

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up2

Baseline characteristics

CharacteristicMaintenance
Age, Continuous56.9 years
STANDARD_DEVIATION 10
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
28 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
4 Participants
Race (NIH/OMB)
More than one race
2 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants
Race (NIH/OMB)
White
22 Participants
Region of Enrollment
United States
30 Participants
Sex: Female, Male
Female
6 Participants
Sex: Female, Male
Male
24 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 30
other
Total, other adverse events
0 / 30
serious
Total, serious adverse events
0 / 30

Outcome results

Primary

Recruitment Rate

Percentage of contacted patients who consent to be in the study

Time frame: week 0

Population: \# of patients for whom phone screening was attempted

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
MaintenanceRecruitment Rate33 Participants
Primary

Retention Rate

Percentage of patients with baseline data who complete 16-week outcome assessments

Time frame: 16-week outcome assessment

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
MaintenanceRetention Rate28 Participants
Secondary

Weight

Patient weight obtained from the electronic medical record on the clinical visit date closest to the 16-week study assessment date

Time frame: 16 weeks

Population: The N=30 is based on the number of participants who provided baseline data according to Intent-to-treat principles

ArmMeasureValue (MEAN)Dispersion
MaintenanceWeight213.7 poundsStandard Deviation 43.1

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026